Paul M. Barr, M.D.

Paul M. Barr, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Professional Bio

Paul M. Barr, M.D. is an Assistant Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Center.





Dr. Barr received his medical degree from Northeast Ohio Medical University. His postgraduate training included an internship, residency and chief residency at Case Western Reserve University. He subsequently completed a hematology and oncology fellowship at Case Western and now holds subspecialty certification in Internal Medicine, Hematology and Oncology.

He is a member of the lymphoma committee in the Southwest Oncology Group and serves as principal investigator on several local and national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

His research interests focus on the development of novel therapeutics for patients with chronic lymphocytic leukemia and lymphoma. He has received a NIH funded K12 award during his training for his work with the organic amine Methoxyamine to improve the effect of fludarabine for CLL patients. Most recently, he was awarded a Clinical Research award from the Lymphoma Research Foundation based o his work developing combination therapies targeting molecules within the B cell receptor pathway for CLL and lymphoma patients.

Research Bio

Paul M. Barr, M.D. is an Assistant Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Center.



Dr. Barr received his medical degree from Northeast Ohio Medical University. His postgraduate training included an internship, residency and chief residency at Case Western Reserve University. He subsequently completed a hematology and oncology fellowship at Case Western and now holds subspecialty certification in Internal Medicine, Hematology and Oncology.

He is a member of the lymphoma committee in the Southwest Oncology Group and serves as principal investigator on several local and national clinical trial treatment protocols for chronic lymphocytic leukemia and non-Hodgkin lymphoma.

His research interests focus on the development of novel therapeutics for patients with chronic lymphocytic leukemia and lymphoma. He has received a NIH funded K12 award during his training for his work with the organic amine Methoxyamine to improve the effect of fludarabine for CLL patients. Most recently, he was awarded a Clinical Research award from the Lymphoma Research Foundation based o his work developing combination therapies targeting molecules within the B cell receptor pathway for CLL and lymphoma patients.

Awards & Honors (Local)

NIH Loan Repayment Program Award Recipient | NIH 2011
American Society of Hematology Clinical Research Training Institute 2009
NIH/NCI K12 Paul Calabresi Scholar | NIH | University Hospitals Case Medical Center, Case Western Resrve 2008
John W. Harris, MD Hematology Scholar Award | Case Western Reserve University 2006 - 2007
Chief Medical Resident | Case Western Reserve University/University Hospitals 2003 - 2004

Recent Journal Articles

Showing the 5 most recent journal articles. 34 available »

2014 Sep
Jahangiri S, Barr P, Friedberg J. "Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma." Expert opinion on emerging drugs. 2014 Sep; 19(3):367-83. Epub 2014 Jun 24.
2014 Aug 21
Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. "Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma." Blood. 2014 Aug 21; 124(8):1259-65. Epub 2014 Jul 11.
2014 Aug
Barr PM. "Maintenance rituximab should be considered for patients with follicular lymphoma." Clinical advances in hematology & oncology : H&O. 2014 Aug; 12(8):541-3.
2014 Jul 17
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P, . "Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia." The New England journal of medicine. 2014 Jul 17; 371(3):213-23. Epub 2014 May 31.
2014 Jul 15
Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. "Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma." Leukemia & lymphoma. 2014 Jul 15; :1-4. Epub 2014 Jul 15.

Current Appointments

Medical Director, Cancer Center Clinical Trials Office - Department of Medicine (SMD)
Assistant Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary
Assistant Professor - Cancer Center

Specialties

Hematology - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine
Internal Medicine - American Board of Internal Medicine

Education

MD | Medicine | Northeastern Ohio Univs Med Sch2000
BA | Zoology | Miami University-Oxford1996

Post-Doctoral Training & Residency

Fellowship in Hematology/Oncology at University Hospitals of Cleveland07/01/2004 - 06/30/2007
Residency in Internal Medicine at University Hospitals of Cleveland07/01/2001 - 06/30/2003
Internship in Internal Medicine at University Hospitals of Cleveland07/01/2000 - 06/30/2001